Abstract:Abstract Background Cervical carcinoma is one of the most common malignant tumors of the female reproductive system. Lymph nodes metastasis, the most common metastasis, which can be detected even in small-size tumor patients, results in worse prognosis. Therefore, it is of great significance to explore novel lymph nodes metastasis associated biomarkers, which can predict the prognosis and provide a good reference for clinical decision making in cervical carcinoma patients. However, systematic and comprehensive studies related to the key molecules in lymph node metastasis in cervical carcinoma patients are still absent. Methods Transcriptome and clinical data of 307 cervical carcinoma patients were obtained from The Cancer Genome Atlas (TCGA). Then, survival of patients with and without lymph node metastasis was analyzed by Kaplan-Meier (K-M) curves. Differential expressed genes (DEGs) were detected between tumor and control samples using limma package and defined as lymph node metastasis related genes. Univariate and multivariate Cox regression analyses were carried out to screen robust prognostic gene signature. The risk score model and nomogram for predicting survival were constructed based on prognostic gene signature. The performance of the risk score model was evaluated by operating characteristic (ROC) curves. Based on risk score, patients were divided into low- and high- risk groups. DEGs, functional enrichment analysis and tumor microenvironment (immune infiltration and expressions of immune checkpoints) were detected in low- and high-risk groups. Results A total of 103 lymph node metastasis-associated genes were identified. Univariate and multivariate Cox regression analyses identified TEKT2, LPIN2, FABP4 and CXCL2 as prognostic gene signature. The risk score model was constructed and validated in cervical carcinoma patients. 345 DEGs identified between high- and low-risk groups were significantly enriched into immune-related biological processes. Furthermore, we found that the immune infiltration and expressions of immune checkpoints were significantly different between low- and high-risk groups. Conclusion Our study revealed that lymph node metastasis played an important role in the prognosis of cervical carcinoma patients. Furthermore, we established a risk score model based on lymph node metastasis related genes, which could accurately predict the survival of cervical carcinoma patients. Besides, our findings in tumor microenvironments of low- and high-risk groups improved our understanding of the relationship between lymph node metastasis related genes and cervical carcinoma.

A Comprehensive Analysis Of Metabolomics And Transcriptomics In Cervical Cancer

A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer

High-throughput metabolomics identifies new biomarkers for cervical cancer

Exploring Metabolomics Biomarkers for Evaluating the Effectiveness of Concurrent Radiochemotherapy for Cervical Cancers.

Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective

Plasma-based proteomic and metabolomic characterization of lung and lymph node metastases in cervical cancer patients

Research progress of metabolomics in cervical cancer

The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer.

Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer

Identification and characterization of differentially expressed genes in cervical cancer: insights from transcriptomic analysis

Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis

Identifying TME signatures for cervical cancer prognosis based on GEO and TCGA databases

Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer

Prognostic Biomarkers of Cervical Squamous Cell Carcinoma Identified Via Plasma Metabolomics.

Metabolome and Transcriptome Integration Reveals Metabolic Profile of Hepatocellular Carcinoma.

Cervicovaginal metabolome and tumor characteristics for endometrial cancer detection and risk stratification

Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis

Identification of Differentially Expressed Genes in Cervical Cancer by Bioinformatics Analysis.

An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single‐base resolution methylome and hydroxymethylome

Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers

Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis